Key Takeaways Women are more likely to survive cancer than menHowever, they also are more likely to develop severe side ...
Resistance to therapy and tumor heterogeneity remain the fundamental drivers of treatment failure in oncology. While single-agent therapies have provided ...
Ovarian cancer (OC) is a "silent killer" with an annual incidence of 11.2 per 100,000 and mortality of 7.6 per 100,000. Most cases are diagnosed at ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...
An innovative care delivery model at Mayo Clinic integrates virtual oversight, remote patient monitoring, mobile health ...
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...
UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T ...
Cancer therapy continues to evolve, with significant advances in precision techniques such as surgery, chemotherapy, immunotherapy, radiotherapy, and ...
The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...